GT Biopharma Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for GT Biopharma.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Dec 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | N/A | -17 | N/A | N/A | 1 |
| 12/31/2023 | N/A | -8 | -9 | -9 | N/A |
| 9/30/2023 | N/A | -10 | -11 | -11 | N/A |
| 6/30/2023 | N/A | -15 | -12 | -12 | N/A |
| 3/31/2023 | N/A | -16 | -13 | -13 | N/A |
| 12/31/2022 | N/A | -21 | -15 | -15 | N/A |
| 9/30/2022 | N/A | -33 | -15 | -15 | N/A |
| 6/30/2022 | N/A | -32 | -16 | -16 | N/A |
| 3/31/2022 | N/A | -34 | -17 | -17 | N/A |
| 12/31/2021 | N/A | -58 | -16 | -16 | N/A |
| 9/30/2021 | N/A | -46 | -14 | -14 | N/A |
| 6/30/2021 | N/A | -44 | -12 | -12 | N/A |
| 3/31/2021 | N/A | -56 | -11 | -11 | N/A |
| 12/31/2020 | N/A | -28 | -7 | -7 | N/A |
| 9/30/2020 | N/A | -23 | -6 | -6 | N/A |
| 6/30/2020 | N/A | -50 | -5 | -5 | N/A |
| 3/31/2020 | N/A | -36 | -3 | -3 | N/A |
| 12/31/2019 | N/A | -39 | -4 | -4 | N/A |
| 9/30/2019 | N/A | -41 | -4 | -4 | N/A |
| 6/30/2019 | N/A | -247 | -7 | -7 | N/A |
| 3/31/2019 | N/A | -254 | -7 | -7 | N/A |
| 12/31/2018 | N/A | -259 | -11 | -11 | N/A |
| 9/30/2018 | N/A | -261 | -12 | -12 | N/A |
| 6/30/2018 | N/A | -156 | -10 | -10 | N/A |
| 3/31/2018 | N/A | -149 | -9 | -9 | N/A |
| 12/31/2017 | N/A | -144 | -5 | -5 | N/A |
| 9/30/2017 | N/A | -141 | N/A | -3 | N/A |
| 6/30/2017 | N/A | -14 | N/A | -2 | N/A |
| 3/31/2017 | N/A | -10 | N/A | -2 | N/A |
| 12/31/2016 | N/A | 10 | N/A | -2 | N/A |
| 9/30/2016 | N/A | -14 | N/A | -3 | N/A |
| 6/30/2016 | N/A | -12 | N/A | -3 | N/A |
| 3/31/2016 | 0 | 14 | N/A | -3 | N/A |
| 12/31/2015 | 0 | -21 | N/A | -5 | N/A |
| 9/30/2015 | 0 | -14 | N/A | -5 | N/A |
| 6/30/2015 | 0 | -17 | N/A | -5 | N/A |
| 3/31/2015 | 0 | -44 | N/A | -3 | N/A |
| 12/31/2014 | 0 | -23 | N/A | -2 | N/A |
| 9/30/2014 | 0 | -5 | N/A | -1 | N/A |
| 6/30/2014 | 0 | -1 | N/A | 0 | N/A |
| 3/31/2014 | 0 | -1 | N/A | 0 | N/A |
| 12/31/2013 | 0 | -1 | N/A | 0 | N/A |
| 9/30/2013 | 1 | -1 | N/A | 0 | N/A |
| 6/30/2013 | 0 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if OXIA's forecast earnings growth is above the savings rate (0.7%).
Earnings vs Market: Insufficient data to determine if OXIA's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if OXIA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if OXIA's revenue is forecast to grow faster than the German market.
High Growth Revenue: OXIA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OXIA's Return on Equity is forecast to be high in 3 years time